We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eli Lilly and Co. and Asahi Kasei Pharma entered a license agreement under which Lilly will acquire the exclusive rights for AK1780 from Asahi Kasei Pharma.